Considering the downstream effect of IL-6 on hepatocyte stimulation [13], serum CRP concentration is seen as a biomarker of disease activity in idiopathic multicentric Castleman disease. The gene discussed is IL6; the disease is idiopathic multicentric Castleman disease.